KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 123 filers reported holding KRYSTAL BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,652 | -9.7% | 4,247 | -8.6% | 0.70% | +13.0% |
| Q2 2023 | $545,558 | -6.2% | 4,647 | -36.0% | 0.62% | -9.3% |
| Q1 2023 | $581,716 | +5.9% | 7,266 | +4.7% | 0.68% | +1.3% |
| Q4 2022 | $549,549 | +109.8% | 6,937 | +84.4% | 0.67% | +134.7% |
| Q3 2022 | $262,000 | -15.5% | 3,762 | -20.4% | 0.28% | -8.9% |
| Q2 2022 | $310,000 | -86.4% | 4,727 | -86.2% | 0.31% | -77.4% |
| Q1 2022 | $2,278,000 | -36.0% | 34,242 | -32.8% | 1.39% | -12.8% |
| Q4 2021 | $3,562,000 | +172.3% | 50,922 | +103.3% | 1.59% | +234.7% |
| Q3 2021 | $1,308,000 | +13.8% | 25,044 | +48.2% | 0.48% | +25.3% |
| Q2 2021 | $1,149,000 | -11.8% | 16,900 | 0.0% | 0.38% | -24.8% |
| Q1 2021 | $1,302,000 | +119.2% | 16,900 | +70.7% | 0.50% | +12.2% |
| Q4 2020 | $594,000 | – | 9,900 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
| S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
| First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
| Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
| Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
| Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
| HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
| DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
| Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
| Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |